Skip to main content
OpenTrials
Completed

NCT Number: NCT06668974

Causal Associations Between Allergic Rhinitis and Asthma

This study investigates the causal relationship between allergic rhinitis and asthma using a bidirectional two-sample Mendelian randomization approach. Genetic data were derived from UK Biobank for allergic rhinitis and from Finnish biobank for asthma. This analysis aims to clarify the potential causal link between these two conditions.

Completed

Looking for future studies?

Notify Me

Key information

Age range

0 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

Guangzhou Institute of Respiratory Diseases, the First Affiliated Hospital of Guangzhou Medical University

Guangzhou, Guangdong, 510120, China

About this study

This observational study utilizes a bidirectional two-sample Mendelian randomization (MR) analysis to examine the causal association between allergic rhinitis and asthma. The genetic data for allergic rhinitis were obtained from the UK Biobank, encompassing 18,934 cases and 64,595 controls, while asthma data were derived from a Finnish biobank, including 20,629 cases and 135,449 controls. The Mendelian randomization analysis was performed using inverse-variance weighting (IVW), Mendelian randomization-Egger (MR-Egger), and weighted median methods to ensure robust causal inference. Additional tests, such as Cochrane's Q test and Mendelian randomization pleiotropy residual sum and outlier (MR-PRESSO), were applied to assess heterogeneity and pleiotropy, enhancing the reliability of the findings. The results are expected to provide insights into the bidirectional causal relationship between allergic rhinitis and asthma, potentially informing future prevention and treatment strategies.

Who can participate

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Individuals diagnosed with allergic rhinitis or asthma.
  • Availability of genetic data in the UK Biobank or Finnish biobank.

Exclusion criteria

  • Individuals without genetic data.
  • Participants with incomplete phenotype or genotype data.

Treatment and study plan

Mendelian Randomization

Other

This study utilizes a bidirectional Mendelian randomization approach to analyze genetic data from individuals with allergic rhinitis and asthma. No active intervention is applied; genetic variants serve as instrumental variables to assess causal associations between the conditions.

Primary outcomes

  1. Causal Effect of Allergic Rhinitis on Asthma Risk

    Time frame: Oct 24 2024

    Estimate the causal effect of allergic rhinitis on asthma risk using bidirectional Mendelian randomization. This measure includes odds ratios (OR) derived from inverse-variance weighting (IVW), Mendelian randomization-Egger (MR-Egger), and weighted median methods.

  2. Causal Effect of Asthma on Allergic Rhinitis Risk

    Time frame: Oct 24 2024

    Estimate the causal effect of asthma on allergic rhinitis risk using bidirectional Mendelian randomization. This measure includes odds ratios (OR) derived from inverse-variance weighting (IVW), Mendelian randomization-Egger (MR-Egger), and weighted median methods.

Secondary outcomes

  1. Sensitivity Analysis Using MR-Egger Intercept Test

    Time frame: Oct 24 2024

    Perform sensitivity analysis using the Mendelian randomization-Egger (MR-Egger) intercept test to assess horizontal pleiotropy in the causal estimates between allergic rhinitis and asthma.

  2. Sensitivity Analysis Using Leave-One-Out Test

    Time frame: Oct 24 2024

    Conduct a leave-one-out test to evaluate the robustness of the causal estimates between allergic rhinitis and asthma by sequentially removing each single nucleotide polymorphism (SNP).

  3. Sensitivity Analysis Using MR-PRESSO

    Time frame: Oct 24 2024

    Use the Mendelian randomization pleiotropy residual sum and outlier (MR-PRESSO) test to detect and correct for outliers, assessing heterogeneity in the causal estimates between allergic rhinitis and asthma.

Sponsors and collaborators

Lead sponsor

Zhibin Xu

Other

Registry information

Official study title

Bidirectional Mendelian Randomization Study Reveals Causal Associations Between Allergic Rhinitis and Asthma

Important dates

Study start
2024
Primary completion
2024
Study completion
2024
First posted
Nov 1, 2024
Registry last updated
Nov 1, 2024

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.